Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
2001
Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation
2002
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines
2004
Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
1996
Orally active growth hormone secretagogues: state of the art and clinical perspectives
1998
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity
2002
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells
2003
Mechanisms of Thrombus Formation
2008 Standout
Nitric oxide and atherosclerosis: An update
2006 Nobel
Protective Effects of Ghrelin on Ischemia/Reperfusion Injury in the Isolated Rat Heart
2004
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Neutrophils, Endothelial Cells, and Cysteinyl Leukotrienes: A New Approach to Neutrophil-Dependent Inflammation?
2001
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Eicosanoid Transcellular Biosynthesis: From Cell-Cell Interactions to in Vivo Tissue Responses
2006
High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli
2005
Rethinking amide bond synthesis
2011 StandoutNature
Ghrelin?a hormone with multiple functions
2004
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
2003
Atheroprotective Effects of High-Density Lipoprotein-Associated Lysosphingolipids
2005
Endocrine and Non-Endocrine Activities of Growth Hormone Secretagogues in Humans
1999
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
2010
Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
2003 Standout
Vascular disorders of the liver # †
2008 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Growth hormone deficiency and vascular risk
2002
Hemodynamic, Renal, and Hormonal Effects of Ghrelin Infusion in Patients with Chronic Heart Failure
2001
Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis
2004
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions
1999
The growth hormone secretagogue receptor
1999
Kidney produces a novel acylated peptide, ghrelin
2000
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes
2004
Time course and quantitative analysis of the adaptive responses to 85% oxygen in the rat lung and heart
2000
Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure
2003
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
[125I‐His9]‐Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up‐regulation of receptors with atherosclerosis
2001
Endogenous mediators that inhibit the leukocyte– endothelium interaction
1997
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Resolution of inflammation: the beginning programs the end
2005 Standout
Growth Hormone Secretagogue Receptor Family Members and Ligands
2001
Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans
1999
Eicosanoids and cancer
2010 Standout
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif
2009 StandoutNobel
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
2006
Impaired vascular function in patients with Fontan circulation
2006
Cysteine string protein‐α is essential for the high calcium sensitivity of exocytosis in a vertebrate synapse
2008 StandoutNobel
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?
2008
Current understanding of the metabolism and biological actions of HDL
2005
Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index
2004 Standout
The hydrogen sulphide‐releasing derivative of diclofenac protects against ischaemia–reperfusion injury in the isolated rabbit heart
2007
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Ghrelin: Structure and Function
2005 Standout
Growth hormone and the heart
2001
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
Synthetic therapeutic peptides: science and market
2009
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
Protective Effect of Defibrotide on Perfusion Induced Endothelial Damage
2000
Polydeoxyribonucleotides and nitric oxide release from guinea‐pig hearts during ischaemia and reperfusion
1995
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2
2009 StandoutNobel
Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure
2003
cPLA2 is phosphorylated and activated by MAP kinase
1993 Standout
Peroxynitrite-Induced Nitrotyrosination of Proteins Is Blocked by Direct 5-Lipoxygenase Inhibitor Zileuton
2001
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Endothelial Protection by High-Density Lipoproteins
2003
Adrenergic Receptors in the Heart
1982
Growth Hormone Releasing Substances: Types and Their Receptors
1999
Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite
2004 Standout
Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases
2018
Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
2011
A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans
2001 Standout
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
2016 Standout
Differential Localization of Voltage-Dependent Calcium Channel α1Subunits at the Human and Rat Neuromuscular Junction
1997
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Ontogenetic development of isoproterenol subsensitivity of myocardial adenylate cyclase and β-adrenergic receptors in spontaneously hypertensive rats
1980
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Dioxygen Activation at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates
2004 Standout
FUNCTIONAL AND BIOCHEMICAL MODIFICATIONS OF LUNG β‐ADRENORECEPTORS AFTERIN VIVODESENSITIZATION: PREVENTION BY INDOMETHACIN
1986
Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-κB Activation in Human Endothelial Cells
2004
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Mechanisms of Membrane-Receptor Regulation
1984 StandoutNobel
Annexins: From Structure to Function
2002 Standout
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
1987 StandoutScienceNobel
Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure
2001
The Metabolic Syndrome
2008 Standout
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT
2002
Valvular endothelial cells and the mechanoregulation of valvular pathology
2007
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
2004
CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart
2002
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Ghrelin protects myocardium from isoproterenol-induced injury in rats.
2004
Antiinflammatory Properties of HDL
2004 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation.
2002 Standout
Proton-Coupled Electron Transfer
2012 Standout
Inhibition of the β-Adrenergic Receptor Kinase by Polyanions
1989 StandoutNobel
Local Anesthetics and the Inflammatory Response
2000 Standout
Works of Ferruccio Berti being referenced
Stimulus-related difference in the formation of leukotrienes and PGD2 after immunological and non-immunological challenge of human lung parenchyma “in vitro”
1986
Ghrelin Plays a Minor Role in the Physiological Control of Cardiac Function in the Rat
2003
Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium
2000
Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: Protection by hexarelin
1997
Nitric oxide modulation of transcellular biosynthesis of cys‐leukotrienes in rabbit leukocyte‐perfused heart
1997
Chronic Oral Defibrotide Counteracts Hypercholesterolemia Noxious Effects on Cardiovascular Function in the Rabbit
1999
Defibrotide has antiischemic activity in perfused rabbit hearts, preventing tissue Ca++ overloading
1992
Endothelial-Dependent Dynamic and Antithrombotic Properties of Porcine Aortic and Pulmonary Valves
1998
Formation of sulphidopeptide‐leukotrienes by cell‐cell interaction causes coronary vasoconstriction in isolated, cell‐perfused heart of rabbit
1993
Vasoconstriction to Polymorphonuclear Leukocytes in the Isolated, Perfused Rabbit Heart: Inhibition by Prostacyclin Mimetics
1996
Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in l-NAME-treated rats
2002
Hexarelin, But Not Growth Hormone, Protects Heart from Damage Induced In Vitro by Calcium Deprivation Replenishment
2001
Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats
2010
Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency
1996
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats
2005
Growth Hormone and Hexarelin Prevent Endothelial Vasodilator Dysfunction in Aortic Rings of the Hypophysectomized Rat
1999
Hyperbaric oxygen worsens myocardial low flow ischemia-reperfusion injury in isolated rat heart
1997
Protectant Activity of Hexarelin or Growth Hormone Against Postischemic Ventricular Dysfunction in Hearts from Aged Rats
1998
ω-Conotoxin GVIA binds to and blocks rat neuromuscular junction
1994
The Nitric Oxide-Releasing Naproxen Derivative Displays Cardioprotection in Perfused Rabbit Heart Submitted to Ischemia-Reperfusion
2004
Leukotrienes in Cardiovascular Diseases
2000
Transcellular metabolism of leukotrienes and regulation of cardiac function
1994
Growth Hormone-Independent Cardioprotective Effects of Hexarelin in the Rat1
1999
High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-α Content and Enhancing Prostaglandin Release
2003
Defibrotide, an antithrombotic substance which prevents myocardial contracture in ischemic rabbit heart
1987
Subsensitivity of Cardiac β-Adrenoceptors in Renal Hypertensive Rats
1979
β-adrenoceptor activation induces prostaglandin E2 generation in guinea-pig trachea
1981
Protective Effects of ITF 296 in the Isolated Rabbit Heart Subjected to Global Ischemia
1995
Protective Effects of ITF 296 in the Isolated Rabbit Heart Subjected to Global Ischemia
1995
Monoclonal Anti-CD18 Antibody Prevents Transcellular Biosynthesis of Cysteinyl Leukotrienes In Vitro and In Vivo and Protects Against Leukotriene-Dependent Increase in Coronary Vascular Resistance and Myocardial Stiffness
2000